Propanc Biopharma Inc PPCB

Healthcare Biotechnology

Propanc Biopharma, Inc. is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on the development of cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development.

OTCPK:PPCB - Post by User

Propanc Biopharma Inc > They

<< Previous

Bullboard Posts

Next >>

Comment by Heikogson Sep 08, 2018 1:41pm

334 Views

Post# 28584716

RE:RE:RE:RE:They

Thanks for the feedback. I am going to hold on to this stock. They are just getting into the trials from what I have read. If the trials are very positive we can expect this thing to explode big time. I suppose it's a 3 month trial or 6 months not sure?

The findings and the research look to be very very promissing and positive.

glta

<< Previous

Bullboard Posts

Next >>

Three junior copper stocks for the long run